FDANonrulemakingFDA-2017-D-0154
Who commented on this docket
Considerations in Demonstrating Interchangeability With a Reference Product
3 organizations filed 3 public comments on Considerations in Demonstrating Interchangeability With a Reference Product, at the Food and Drug Administration. The comment window closed 707d ago.
Organizations
3
Comments
3
RIN
—
Comment window
closed 707d ago
Commenters (3)
- American Medical Associationtrade assoc.1 filing · confidence 97%
- Association for Accessible Medicinestrade assoc.1 filing · confidence 97%
- Parenteral Drug Associationtrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.